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The aim of this study was to compare the cytotoxicity of accelerated-set white MTA (AWMTA)
and accelerated-set Malaysian white PC (AMWPC) on stem cells from human exfoliated
deciduous teeth (SHED). The test materials were introduced into paraffin wax moulds after
mixing with calcium chloride dihydrate and sterile distilledwater. Subsequently, the set cement
specimens were sterilized, incubated in a prepared Dulbecco’s modified Eagle medium (DMEM)
for seven days. The biomarker CD166 was used for characterization of SHED using flow
cytometry. The material extracts were diluted at five different concentrations and incubated for
72 h with SHED. The cell viability was evaluated using Dimethylthiazol diphenyltetrazolium
bromide (MTT) assay, and the datawas analysed using Mann–Whitney test (Po0.05). The results
showed that AWMTA revealed significantly greater cell viability at 25 and 12.5mg/ml
concentrations (Po0.05). Concomitantly, AMWPC exhibited greater cell viability at concentra-
tions o12.5mg/ml and the results were significant at 1.563mg/ml (Po0.05). Both materials
demonstrated moderate cytotoxicity at 25mg/ml and slight cytotoxicity at 6.25 and 3.125mg/
ml. At 1.563mg/ml, no cytotoxic activity was merely observed with AMWPC. In conclusion,
AMWPC exhibited favourable and comparable cell viability to that of AWMTA, and has the
potential to be used as an alternative and less costly material in dental applications.
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Mineral trioxide aggregate (MTA) is one of the most biocompa-
tible endodontic materials that exhibits many advantageous
properties including good sealing ability and favourable induc-
tion of dentin bridge formation [1,2]. Owing to these desirable
properties, MTA is indicated for a wide range of clinical
applications such as vital pulp therapy, root end fillings, repair
of perforations and resorption defects [3,4]. Despite this favour-
able biological profile, MTA has some shortcomings, including
long setting time (E3 h), poor handling properties and high
cost [3,5–7].
Portland cement (PC) has many common chemical and
physical properties with MTA, and has been suggested as a
viable substitute for MTA due to its lower cost [8]. However,
PC also has similar disadvantages including long setting time
and poor handling properties [3] that would favour its
solubility, disintegration and dislodgement, especially when
applied as a root end filling material [5].
In an attempt to decrease the setting time, some setting
accelerators such as calcium chloride, calcium formate and
NaOCl gel have been suggested as additives [5,9]. Some studies
found that CaCl2 has not only the ability to reduce the setting
time of MTA and PC from 3 h to 20–30min, but it also enhances
the sealing ability and increases the release of calcium ions
while maintaining a high pH [1,10]. The addition of CaCl2 to
MTA and PC did not alter their biocompatibility [1,10].
The regenerative techniques via stem cell therapy are
considered currently as promising areas for research and
therapeutic applications in dentistry. Stem cells of human
exfoliated deciduous teeth (SHED) are a population of
postnatal mesenchymal stem cells capable of extensiveFig. 1 – (a) Confluent SHED (P3), (b) paraffin wax supported b
materials.
Table 1 – Composition of both test materials (AWMTA
and AMWPC).
Test
materials
Composition
AWMTA 1 g of ProRoot tooth-coloured (white) Mineral
Trioxide Aggregate (WMTA, Dentsply, USA)þ10%
calcium chloride dihydrate (Merck,
Germany)þ200 ml sterile distilled water.
AMWPC 1 g of 63 mm sieved Malaysian white Portland
cement (MWPC, Aalborg, Malaysia)þ10% calcium
chloride dihydrate (Merck, Germany)þ250 ml sterile
distilled water.proliferation and multi-potential differentiation. SHED were
first isolated by Miura and co-workers in 2003 [11]. They have
high plasticity, easy to be expanded in vitro and are readily
accessible from exfoliating deciduous teeth of young patients
[11]. SHED can be characterized by a few methods, among
which are immunocytochemistry, Reverse Transcriptase-
Polymerase Chain Reaction (RT-PCR) and flow cytometry
[11–13]. Flow cytometry is a powerful technique that identi-
fies the presence of antigens either on the surface of or
within the cells [12]. In this instance, Cluster of Differentia-
tion (CD) 166 is one of the most commonly used mesenchy-
mal stem-cell surface markers that are positively expressed
by SHED [12,13].
MTA and PC have shown favourable biocompatibility with
various cell lines, including osteosarcoma cells, mouse lym-
phoma cells and human endothelial cells [1,14–16]. Never-
theless, within the limits of our knowledge, no study has
been carried out to investigate the cytotoxicity of accelerated
setting white MTA (AWMTA) and accelerated setting Malay-
sian white PC (AMWPC), using calcium chloride dihydrate as
the accelerator, on SHED.Materials and methods
The cryopreserved SHED were obtained from a previous work
[13] (the Craniofacial Laboratory, School of Dental Sciences
Universiti Sains Malaysia). SHED were thawed, cultured and
incubated at 37 1C in 5% CO2. Confluent cells (Fig. 1a) were
detached using 0.25% trypsin, and then sub-cultured. The
experiment was performed at passage 3 after characteriza-
tion using a stem cell surface marker (CD166, PE stain,
BioLegend, San Diego, USA) examined by a flow cytometry
(BD FACS Canto II, Canada).
A pilot study which used different liquid to powder ratios
for mixing MTA and Portland cement has been attempted in
order to obtain an ideal consistency for both materials.
Table 1 shows the values with regards to the amount of
water that demonstrated ideal consistency and handling
properties for AWMTA and AWMPC.
The mixed materials were applied into paraffin wax
moulds supported by stainless steel (SS) (diameter 1.5 cm
and 2 mm depth) [17] (Fig. 1b). After 24 h, the set materials
were sterilized under ultraviolet (UV) radiation (Purifier Class
II Biosafety Cabinet, Labconco, USA) (Fig. 1c) for 30 min
(15 min on each side). The materials were then incubated in
a prepared DMEM solution at 37 1C for 7 days. Subsequently,
the mixed materials were filtered (0.45 mm).y stainless steel mould and (c) UV sterilization of the set
Fig. 2 – (a) Flow cytometry of the control group and (b) flow cytometry showing the positive expression of CD166 by SHED
(98.5%).
Fig. 3 – Cell viability values of AWMTA and AMWPC on SHED after 72 h. The cell viability is classified into severe, moderate,
slight and non-cytotoxic [18], as shown in the table beside.
Fig. 4 – Microscopic images after an immediate application of the material extracts at 25 mg/ml on SHED. (a) AWMTA and
(b) AMWPC. AMWPC shows more leachable particles than AWMTA.
Table 2 – Statistical analysis, using Mann–Whitney test, between the cytotoxicity of AWMTA and AMWPC.
Concentration (mg/ml) n AWMTA Median (IQR) AMWPC Median (IQR) z-statistics P-value
25 12 56.14 (3.90) 38.77 (5.15) 4.16 o0.001n
12.5 12 62.64 (8.26) 55.18 (6.43) 2.77 0.006n
6.25 12 73.29 (7.99) 77.54 (9.08) 1.73 0.083
3.125 12 79.27 (12.67) 85.09 (15.93) 1.96 0.050nn
1.5625 12 85.90 (13.78) 95.55 (11.66) 2.28 0.023n
n Statistically significant (Po0.05).
nn Marginally significant (Po0.05).
S i n g a p o r e D e n t a l J o u r n a l 3 3 ( 2 0 1 2 ) 1 9 – 2 3 21
S i n g a p o r e D e n t a l J o u r n a l 3 3 ( 2 0 1 2 ) 1 9 – 2 322After seeding SHED into the 96-well plates for 24 h, the
media were replaced by 200 ml of the extracts (12 replicates for
each concentration), and the last row served as the control
group. The plates were then incubated at 37 1C and 5% CO2 for
a further 72 h.
At the end of that 72-h period, 30 ml of Dimethylthiazol
diphenyltetrazolium bromide (MTT) (5 mg/ml) was added into
the 200 ml extract, and incubated at 37 1C and 5% CO2 for 4 h.
Then, the medium was replaced by 200 ml of dimethyl sulf-
oxide (DMSO). The optical density was measured using ELISA
reader (Sunrise, Tecan) at the reference wavelength of 630 nm
and the test wavelength of 570 nm.
The data collected were analysed using Predictive Analytics
Software (PASW) Statistics version 18.0 (SPSS Inc., Chicago IL)
using Mann–Whitney test with the level of significance set at
Po0.05.Results
Flow cytometry analysis demonstrated that the CD marker
(CD166) used to define the cryopreserved SHED was positively
expressed by over 95% (Fig. 2). For cytotoxicity evaluation, the
results show that at higher concentrations, AWMTA allowed
greater cell viability values at 25 and 12.5 mg/ml concentra-
tions than AMWPC, that released more particles than
AWMTA (Figs. 3 and 4), and the difference was statistically
significant (Po0.05) (Table 2). AMWPC exhibited greater cell
viability at concentrationso12.5 mg/ml, and the results were
significant at 1.563 mg/ml (Po0.05) (Table 2). Both materials
demonstrated moderate cytotoxicity at 25 mg/ml and slight
cytotoxicity at 6.25 and 3.125 mg/ml. At 1.563 mg/ml, no
cytotoxic activity was merely observed with AMWPC (Fig. 3).Discussion
MTA generally refers to the original formulation, which was
grey in colour, (GMTA) and was first introduced by Torabine-
jad and White in 1993 [19]. It is basically a refined mixture of
Portland cement and bismuth oxide [20]. Due to the disco-
louration potential of this grey formulation to teeth and the
supporting gingival [21], tooth-coloured (white) MTA (WMTA)
was then introduced as a more suitable material for use in
applications where discolouration of dental tissues became
an aesthetic concern.
Despite the significant improvement in aesthetics, the long
setting time of MTA still remained as its main drawback. The
setting time has been reduced significantly by the addition of
CaCl2 [5,9,22]. Apart from the reported favourable biological
profile of this accelerated formulation, its clinical application
into areas where the moisture control is difficult to
achieve would reduce the risk of contamination, especially
during commencing highly complicated technique sensitive
procedures such as pulp tissue regeneration via stem cell
therapy.
Calcium chloride is a hygroscopic chemical compound that
can be presented in different formulations. The dihydrate
formula (CaCl2 .2H2O) was chosen in this study due to its
lesser hygroscopic nature than its anhydrous formulation.This provides easier manipulation, and permit adequate time
for proportioning before its addition to WMTA and MWPC.
In our investigation, a pilot study has been performed to
determine the most suitable liquid to powder ratio that
would exhibit the best handling properties of both materials
in view of their application in critical clinical conditions such
as during treatment of root perforations and retrograde
fillings. Obtaining an ideal consistency of both materials is
essential because the use of higher liquid to powder ratio
during mixing would result in a more porous and soluble
material that may leach more particles during the incubation
time, thus masking the actual viability of the cultured cells
and invalidating the results. In the meantime, Fridland and
Rosado [23] found that the difference in liquid to powder
ratios of Portland cement based materials, such as MTA, may
affect the physical properties of the material including
porosity and solubility. Nevertheless, when the material is
incorporated into a biological system, such as the dental
pulp, it seems that the difference in liquid to powder ratios of
MTA do not have a significant influence on the histological
outcomes [24].
In an attempt to obtain an accurate cytotoxicity evaluation
via MTT assay, the maximum concentration of the material
extracts was set at 25 mg/ml. This probably would correspond
to the small amount of endodontic bio-materials usually
indicated for vital pulp therapy, retro-grade filling and repair
of perforation defects, in which, only one surface of the
material is in direct contact with the pulp or periodontal
tissues.
Our results demonstrated that both AWMTA and AMWPC
at 25 mg/ml were cytotoxic to SHED. This is in agreement
with a study by Hakki et al. [25], who found that 20 mg/ml of
white MTA decreased the cell survival of OCCM-30 cemento-
blasts. AMWPC is significantly more cytotoxic than AWMTA
at concentrations 25 and 12.5 mg/ml. Nevertheless, at 3.25
and 1.5625 mg/ml, the cell viability is significantly higher
when compared to that of AWMTA. In addition, AMWPC is
defined as non-cytotoxic at 1.5625 mg/ml, which is not
represented with AWMTA. These fluctuating results at differ-
ent concentrations might be attributed to the inherent
biological effects of the leachable particles released from
both materials, being more benign in AMWPC, when the
extracts become diluted.Conclusion
AMWPC exhibited favourable and comparable cell viability to
that of AWMTA, and may have the potential to be used as an
alternative material in dental applications.Acknowledgement
This study was supported by Universiti Sains Malaysia (USM)
Short Term Grant no. 304/PPSG/61310020. The ethical
approval was obtained from the Research Ethics Committee
(Human), Universiti Sains Malaysia vide reference USMKK/
PPP/JEPeM [236.4.(2.12)] dated 23rd April 2011. The authors are
grateful to the staffs at the Craniofacial Science Laboratory,
S i n g a p o r e D e n t a l J o u r n a l 3 3 ( 2 0 1 2 ) 1 9 – 2 3 23School of Dental Sciences, Mr. Jamal (Department of Immu-
nology) and Ms. Aliah (Department of Medical Statistics),
School of Medical Sciences, USM for their technical and
statistical support.
r e f e r e n c e s
[1] D. Abdullah, T.R. Pitt Ford, S. Papaioannou, J. Nicholson, F.
McDonald, An evaluation of accelerated Portland cement as
a restorative material, Biomaterials 23 (2002) 4001–4010.
[2] D. Tziafas, O. Pantelidou, A. Alvanou, G. Belibasakis, S.
Papadimitriou, The dentinogenic effect of mineral trioxide
aggregate (MTA) in short-term capping experiments, Inter-
national Endodontic Journal 35 (2002) 245–254.
[3] M. Parirokh, M. Torabinejad, Mineral trioxide aggregate: a
comprehensive literature review—Part III: clinical applica-
tions, drawbacks, and mechanism of action, Journal of
Endodontics 36 (2010) 400–413.
[4] C. Main, N. Mirzayan, S. Shabahang, M. Torabinejad, Repair
of root perforations using mineral trioxide aggregate: a long-
term study, Journal of Endodontics 30 (2004) 80–83.
[5] P. Kogan, J. He, G.N. Glickman, I. Watanabe, The effects of
various additives on setting properties of MTA, Journal of
Endodontics 32 (2006) 569–572.
[6] J. Saidon, J. He, Q. Zhu, K. Safavi, L.S. Spa˚ngberg, Cell and
tissue reactions to mineral trioxide aggregate and Portland
cement, Oral Surgery, Oral Medicine, Oral Pathology, Oral
Radiology, and Endodontology 95 (2003) 483–489.
[7] M. Torabinejad, C.U. Hong, F. McDonald, T.R. Pitt Ford,
Physical and chemical properties of a new root-end filling
material, Journal of Endodontics 2 (1995) 349–353.
[8] C. Estrela, L.L. Bammann, R.S. Silva, J.D. Pe´cora, Antimicro-
bial and chemical study of MTA, Portland cement, calcium
hydroxide paste, sealapex and dycal, Brazilian Dental Journal
11 (2000) 3–9.
[9] K.B. Wiltbank, S.A. Schwartz, W.G. Schindler, Effect of
selected accelerants on the physical properties of mineral
trioxide aggregate and Portland cement, Journal of Endodon-
tics 33 (2007) 1235–1238.
[10] E.A. Bortoluzzi, N.J. Broon, C.M. Bramante, R.B. Garcia, I.G.
Moraes, N. Bernardineli, Sealing ability of MTA and radio-
paque Portland cement with or without calcium chloride
for root-end filling, Journal of Endodontics 32 (2006)
897–900.
[11] M. Miura, S. Gronthos, M. Zhao, B. Lu, L.W. Fisher, P.G. Robey,
SHED: stem cells from human exfoliated deciduous teeth,
Proceedings of the National Academy of Sciences of the
United States of America 100 (2003) 5807–5812.
[12] A.N. Lutfi, T.P. Kannan, M.N. Fazliah, M.A. Jamaruddin, J.
Saidi, Proliferative activity of cells from remaining dentalpulp in response to treatment with dental materials, Aus-
tralian Dental Journal 55 (2010) 79–85.
[13] M.A.B. Hilmi, S.N. Fazliah, A.S. Fadilah, H. Asma, A.R.S.
Razila, S. Shaharum, S. Jaafar, A.B. Asiah, O. Shamsuria,
Stem cells from children teeth, Archives of Orofacial
Sciences 3 (2008) 29–31.
[14] J. Camilleri, F. Montesin, L. Di Silvio, T.R. Pitt Ford, The
chemical constitution and biocompatibility of accelerated
Portland cement for endodontic use, International Endodon-
tic Journal 38 (2005) 834–842.
[15] G. De Deus, R. Ximenes, E.D. Gurgel-Filho, M.C. Plotkowski, T.
Coutinho-Filho, Cytotoxicity of MTA and Portland cement on
human ECV 304 endothelial cells, International Endodontic
Journal 38 (2005) 604–609.
[16] D.A. Ribeiro, M.A. Duarte, M.A. Matsumoto, M.E. Marques,
D.M. Salvadori, Biocompatibility in-vitro tests of mineral
trioxide aggregate and regular and white Portland cements,
Journal of Endodontics 31 (2005) 605–607.
[17] H.M.A. Ahmed, N.S. Omar, N. Luddin, R. Saini, D. Saini,
Cytotoxicity evaluation of a new fast set highly viscous
conventional glass ionomer cement with L929 fibroblast cell
line, Journal of Conservative Dentistry 14 (2011) 406–408.
[18] T.E. Bryan, K. Khechen, M.G. Brackett, et al., In vitro osteo-
genic potential of an experimental calcium silicate
based root canal sealer, Journal of Endodontics 36 (2010)
1163–1169.
[19] M. Torabinejad, N. Chivian, Clinical applications of mineral
trioxide aggregate, Journal of Endodontics 25 (1999) 197–205.
[20] J. Camilleri, F.E. Montesin, K. Brady, R. Sweeney, R.V. Curtis,
T.R. Pitt Ford, The constitution of mineral trioxide aggregate,
Dental Materials 21 (2005) 297–303.
[21] E.A. Bortoluzzi, G.S. Arau´jo, J.M.G. Tanomaru, M. Tanomaru-
Filho, Marginal gingiva discoloration by gray MTA: a case
report, Journal of Endodontics 33 (2007) 325–327.
[22] H.M.A. Ahmed, R. Saini, Ismail Ab. Rahman, D. Saini, Effect
of bee products on the setting properties of mineral trioxide
aggregate mixed with calcium chloride dihydrate. A preli-
minary study, Journal of ApiProduct and ApiMedical Science
3 (2011) 123–127.
[23] M. Fridland, R. Rosado, Mineral trioxide aggregate (MTA)
solubility and porosity with different water-to-powder ratios,
Journal of Endodontics 29 (2003) 814–817.
[24] A. Shahravan, S.P. Jalali, M. Torabi, A.A. Haghdoost, H.
Gorjestani, A histological study of pulp reaction to various
water/powder ratios of white mineral trioxide aggregate as
pulp-capping material in human teeth: a double-blinded,
randomized controlled trial, International Endodontic Jour-
nal 44 (2011) 1029–1033.
[25] S.S. Hakki, S.B. Bozkurt, E.E. Hakki, S. Belli, Effects of mineral
trioxide aggregate on cell survival, gene expression asso-
ciated with mineralized tissues, and biomineralization of
cementoblasts, Journal of Endodontics 35 (2009) 513–519.
